AYAL Capital Advisors’s Calumet Specialty Products CLMT Stock Holding History

AYAL Capital Advisors’s Portfolio CLMT Stock Details CLMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.41M	Buy	+95,000	New	+$2.46M	0.92%	38

Other funds holding CLMT

TSC

Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WDOM

Wasserstein Debt Opportunities Management New York $189M AUM 169.75% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

AAA

Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

AYAL Capital Advisors's CLMT Position: Q1 2026 in Review

AYAL Capital Advisors reduced its Calumet Specialty Products (CLMT) stake by 22% in Q1 2026, selling an estimated $1.12M and leaving 151,877 shares worth $5.45M. The position accounts for 1.48% of the portfolio, ranked #21.

AYAL Capital Advisors first reported a position in CLMT in Q2 2025 and has held it in 4 quarters since. The position peaked at $7.6M in Q3 2025. 180 funds tracked by Wall St. Rank hold CLMT as of Q1 2026.

AYAL Capital Advisors held 151,877 shares of Calumet Specialty Products worth $5.45M as of Q1 2026.
AYAL Capital Advisors sold 43,123 Calumet Specialty Products shares in Q1 2026, an estimated $1.12M.
Calumet Specialty Products made up 1.48% of AYAL Capital Advisors's portfolio in Q1 2026, its #21 holding.
AYAL Capital Advisors first reported a position in Calumet Specialty Products in Q2 2025 and has held it in 4 quarters since.
AYAL Capital Advisors's Calumet Specialty Products position peaked at $7.6M in Q3 2025.
180 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q1 2026.

Based on AYAL Capital Advisors's 13F filing for Q1 2026, filed 15 May 2026.